The Rise of Domestic Manufacturing: What It Means for Commercial Supply Chain Strategy
Strategy Reshoring isn’t a trend — it’s a structural shift that will redefine pharma operations for the next decade. Tariffs, geopolitical instability, and FDA policy shifts are accelerating the move toward domestic manufacturing. But the impact goes far beyond facility location. It reshapes sourcing strategies, capacity planning, cost structures, and risk models across the entire […]